FCP OP MEDICAL BioHealth Trends FCP OP ... - Sal. Oppenheim

PERFORMANCE
Leading position in performance comparison with other biotech funds
140
120
100
80
60
40
PEER FUND COMPARISON
Indexed representation: 30 30.10.2000 10 2000 = EUR 100
20
10/00 10/01 10/02 10/03 10/04 10/05 10/06 10/07 10/08 10/09 10/10 10/11 10/12
FCP OP MEDICAL BioHe@lth-Trends Share Anteilklasse class EUR EUR ESPA Stock Biotec T Dexia Eqs L Biotechnology C Acc
PF (LUX) Biotech P Cap SEB Concept BioTech B Allianz RCM Biotechnologie A EUR
Franklin Biotechnology Disc A Acc $ ING (L) Invest Biotechnology P USD Acc Nordea-1 Biotech BP
CS EF (Lux) Global Biotech Aberdeen B UBS (LUX) EF Biotech B USD P DWS Biotech-Aktien Typ O
BNPP L1 Equity World Biotech Acc Lacuna - APO BioTech Oyster Oncology USD
Since its issue on
30.10.2000, the FCP
Medical BioHealth-
Trends has
significantly
outperformed funds
in the reference
group group.
Peer group funds
focus primarily on
stocks with higher
capitalisation.
Source for FCP OP MEDICAL BioHealth-Trends data: Oppenheim Asset Management Services S.à r.l. , performance calculated according to BVI method /
Source for peer funds: Datastream / Initial charges (for investment and reinvestment) as well as individual costs such as the custodian fee were not included.
Performance would turn out lower if these charges and costs were included included. Growth in the past is no indication of future performance and no guarantee of
success in the future. As of: 06/30/2012
06/30/2012| Page 36 Oppenheim Asset Management Services S.à r.l.